Navigation Links
Syndication Inc. Board of Directors Authorizes the CEO to Rescind 300 Million Shares of the Company's Common Stock to Treasury
Date:2/24/2009

DAMASCUS, Md., Feb. 24 /PRNewswire-FirstCall/ -- Syndication Inc., (Pink Sheets: SYNJ), reports that on February 25th 2009, The BOD of Syndication authorized the CEO to take the necessary steps to rescind 300 million issued and outstanding shares of the Company's Common Stock to the Treasury. The Company maintains that the action taken by the Board is one of many that embrace a comprehensive Company Capitalization Policy designed to increase equity valuation, enhance the potential for equity investment, discourage short trading activity and, most importantly foster a longer term investor attitude.

Other then the reverse split of the Company's common stock initiated last year on November 6th 2008, the Company currently has no intention or plans to do another at any time in the near future. The Company indicates that as of February 18th 2009 the estimated issued and outstanding non-restricted tradable float was just shy of 658 million shares. "The reverse split, pending Stock Dividend and stock rescission are all strategies designed to set up the capitalization structure of the Company in a way that best promotes the potential for the increased valuation of our Company's stock in the trading markets. However, and more importantly, the actions taken by the BOD are intended to reward our shareholders for their continued interest and support while establishing policy designed to encourage a longer term investment position. It is my position, depending on the results and reception of this first Stock Dividend, to recommend that the Board consider establishing policy that routinely pays a dividend of this type on a consistent and timely basis," said Sorrentino, the CEO of Syndication. The Company indicates that more news on the pending dividend, our green energy development and the Sy-Med Spinal Decompression Division is pending.

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products, which we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.


'/>"/>
SOURCE Syndication Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Syndication Inc. Seeks Director of Marketing for Sy-Med Decompression Centers; BOD Considers Adding a Green Energy New Company Subsidiary to its Ranks
2. CRN Announces Syndication Launch for Recovery Talk Network
3. Venezuelan Kidney Expert Joins Herbalifes Nutrition Advisory Board
4. The Hanover Insurance Group Elects Harriett Tee Taggart to Board of Directors
5. The Advisory Board Company to Simulcast Presentation at the Credit Suisse 11th Annual Global Services Conference
6. MedVance Institute Promotes John L. Hopkins to Chairman of the Board of Directors
7. Covance Elects Bradley T. Sheares to Companys Board of Directors
8. Brickson Diamond Appointed Board Chair of National Hospice Foundation
9. Mardil Inc. Appoints Medical Device Veteran Daniel A. Pelak to Its Board of Directors
10. Beth Israel Deaconess Urged to Investigate Member of Board of Overseers Who Raised Millions for Madoff
11. Ralph Alvarez Elected to Lilly Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: